Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Palliative antineoplastics in ovarian cancer

high cost, modest outcome

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Palliative antineoplastics in ovarian cancer. Pharmacoecon. Outcomes News 112, 9 (1997). https://doi.org/10.1007/BF03271605

    Download citation


    • Ovarian Cancer
    • Paclitaxel
    • Palliative Care
    • Carboplatin
    • Home Care